StockData
Atossa Therapeutics, Inc. logo

Atossa Therapeutics, Inc. (ATOS) stock

ATOSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30
$1.90−0.03 (-1.55%)

Close on Nov 17, 2026Market cap $18.96MP/E –Yield –

Atossa Therapeutics gross margin

Gross margin is gross profit as a percentage of revenue.

For fiscal 2015 it was -7431.9%, against 100.0% the year before. The highest annual figure on record is 100.0% in fiscal 2014.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2015Dec 31, 2015-7431.9%−7531.9
FY2014Dec 31, 2014100.0%+78.3
FY2013Dec 31, 201321.7%−64.7
FY2012Dec 31, 201286.4%+6465.7
FY2011Dec 31, 2011-6379.3%–

More Atossa Therapeutics figures

See a number that looks wrong?